NervGen, a publicly traded clinical-stage biotech company based in Vancouver, collaborated with our agency to develop a new website that reflects its clinical stage and strategic focus. Its new digital presence features updated modern branding, along with an updated design, improving its usability, messaging, and strategic direction.
They hired our digital agency to lead a full brand evolution alongside their website redesign, at a moment when the company was facing more opportunity than ever before. Their team knew their existing site no longer matched the stage of the company they had become.
Their team had a specific challenge with their existing logo. They wanted an evolution rather than a full rebrand, something that kept enough familiarity for their growing investor base while giving the brand a flexible, standalone mark to build around.
Beyond the visual identity, NervGen needed their new website to do something their old one never had: properly explain what spinal cord injury actually looks like. The site needed to speak to patients and advocates, and investors all at once, without losing credibility with any of them.